Middle-East and Africa Colorectal Cancer Market Information, by Type (Adenocarcinomas, Carcinoid Tumors, Gastrointestinal Stromal Tumors (GISTs), Lymphomas, Sarcomas), Diagnosis (Faecal Occult Blood Test, Colonoscopy, Virtual Colonoscopy, Stool DNA Test, Digital Rectal Examination, Flexible Sigmoidoscopy, Biopsy, Magnetic resonance Imaging (MRI) and Others), Treatment Type (Surgery, Radiation Therapy, Chemotherapy, Targeted Drug Therapy and others) - Forecast to 2027

Market Synopsis of Middle-East and Africa Colorectal Cancer Market:

Market Scenario:

The colon and rectum belong to our body's digestive system - together they are also known as the large bowel. Colorectal cancer is cancer that starts in the colon or rectum. Colorectal cancer (CRC), also known as bowel cancer and colon cancer. The colon absorbs water and nutrients from the food and stores waste matter (stool). Stool moves from the colon into the rectum before it leaves the body. Each year, around 5,000 Saudis are diagnosed with having cancer, such as colon cancer and breast cancer. Middle-East and Africa Colorectal Cancer market is growing steadily. The market is growing at the CAGR of 1.8% and expected to reach to US$ 0.90 billion by 2022.

Study Objectives of Middle-East and Africa Colorectal Cancer Market:

• To provide detailed analysis of the market structure along with forecast for the next 5 years of the various segments and sub-segments of the Middle-East and Africa Colorectal Cancer market


• To provide insights about factors affecting the market growth


• To analyze the Middle-East and Africa Colorectal Cancer market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.


• To provide historical and forecast revenue of the market segments and sub-segments with respect to two main geographies and their countries- Middle East & Africa.


• To provide country level analysis of the market with respect to the current market size and future prospective


• To provide country level analysis of the market for segments by type, by diagnosis, by treatment type and its sub-segments.


• To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market


• To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the Middle-East and Africa Colorectal Cancer market.

Middle-East and Africa Colorectal Cancer Market by Treatment Type

Intended Audience

• Middle-East and Africa Colorectal Cancer Equipment manufacturers


• Middle-East and Africa Colorectal Cancer Equipment Suppliers


• Government and Independent Regulatory Authorities


• Research and Development (R&D) Companies


• Independent Research Laboratories


• Market Research and Consulting Service Providers


• Medical Research Laboratories

Segments:

Middle-East and Africa Colorectal Cancer market has been segmented on the basis of type which Adenocarcinomas, Carcinoid tumors, Gastrointestinal stromal tumors (GISTs), Lymphomas, Sarcomas, and others. On the basis of diagnosis the market is segmented into Faecal Occult Blood Test, Colonoscopy, Virtual Colonoscopy, Stool DNA test, Digital Rectal Examination, Flexible Sigmoidoscopy, Biopsy, Magnetic resonance imaging (MRI), and Others. On the basis of treatment type market is segmented into Surgery, Radiation Therapy, Chemotherapy, targeted drug therapy, and others.

Regional Analysis of Middle-East and Africa Colorectal Cancer Market:                    

Considering the Middle-East and Africa Colorectal Cancer Market scenario, UAE region is believed to be the largest market for Middle-East and Africa Colorectal Cancer. Moreover Saudi Arabia market is also growing and second largest market for Patient monitoring devices. On the other hand, Egypt market is expected to grow at the steady pace in the Middle-East and Africa Colorectal Cancer during the forecasted period. Rest of the Middle East and Africa region is likely to have a limited but steady growth in the market.

Key Players for Middle-East and Africa Colorectal Cancer Market:         

Some of the key players in this market are: F. Hoffmann-La Roche Ltd (Switzerland), Amgen Inc. (US), Novartis AG(Switzerland), Abbott (US), Beckman Coulter Inc. (US), Debiopharm Group (Switzerland), AbbVie Inc. (US), Bayer AG (Germany).

The report for Middle-East and Africa Colorectal Cancer Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions

Report Scope:

Report Attribute/Metric	Details
Market Size	USD 0.9 Billion
CAGR	1.8% (2016-2022)
Base Year	2019
Forecast Period	2020-2027
Historical Data	2018
Forecast Units	Value (USD Billion)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered	Type, Diagnosis and Treatment Type
Geographies Covered	UAE, Saudi Arabia, Egypt
Key Vendors	F. Hoffmann-La Roche Ltd (Switzerland), Amgen Inc. (US), Novartis AG(Switzerland), Abbott (US), Beckman Coulter Inc. (US), Debiopharm Group (Switzerland), AbbVie Inc. (US), Bayer AG (Germany)
Key Market Opportunities	Joint ventures, strategic alliances, mergers and acquisitions, new product developments
Key Market Drivers	technological advancement, macro economical and governing factors